Feifei Yang

2.2k total citations
83 papers, 1.5k citations indexed

About

Feifei Yang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Feifei Yang has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Feifei Yang's work include Histone Deacetylase Inhibitors Research (22 papers), Protein Degradation and Inhibitors (12 papers) and Inflammatory Bowel Disease (9 papers). Feifei Yang is often cited by papers focused on Histone Deacetylase Inhibitors Research (22 papers), Protein Degradation and Inhibitors (12 papers) and Inflammatory Bowel Disease (9 papers). Feifei Yang collaborates with scholars based in China, United States and Canada. Feifei Yang's co-authors include Yihua Chen, Na Zhao, Di Ge, William E. Friedrichs, B H Bowman, Mingyao Liu, Zhengfang Yi, Hua Zhang, Jingjie Li and Liying Ma and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Feifei Yang

75 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Yang China 23 748 298 234 188 167 83 1.5k
Fernando Rodríguez‐Serrano Spain 22 639 0.9× 270 0.9× 243 1.0× 173 0.9× 80 0.5× 79 1.5k
Robert A. Mook United States 24 1.2k 1.6× 337 1.1× 369 1.6× 120 0.6× 106 0.6× 38 1.9k
Andrei Leitão Brazil 21 613 0.8× 456 1.5× 257 1.1× 100 0.5× 227 1.4× 72 1.7k
Karson S. Putt United States 21 699 0.9× 254 0.9× 413 1.8× 81 0.4× 87 0.5× 42 1.5k
Sumit Siddharth India 28 1.0k 1.4× 189 0.6× 594 2.5× 316 1.7× 190 1.1× 57 1.9k
Shakti Ranjan Satapathy India 22 606 0.8× 183 0.6× 285 1.2× 141 0.8× 56 0.3× 45 1.2k
Narges Baluch Canada 11 1.1k 1.4× 223 0.7× 475 2.0× 236 1.3× 76 0.5× 17 2.2k
Karmen Stankov Serbia 20 480 0.6× 240 0.8× 303 1.3× 66 0.4× 148 0.9× 64 1.5k
Xiaojuan Hou China 19 511 0.7× 195 0.7× 356 1.5× 131 0.7× 166 1.0× 55 1.1k

Countries citing papers authored by Feifei Yang

Since Specialization
Citations

This map shows the geographic impact of Feifei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Yang more than expected).

Fields of papers citing papers by Feifei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Yang. The network helps show where Feifei Yang may publish in the future.

Co-authorship network of co-authors of Feifei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Yang. A scholar is included among the top collaborators of Feifei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Yang. Feifei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Xinlin, Ge Zhang, & Feifei Yang. (2025). A sound-sensitive neuron incorporating a memristive-ion channel. Chinese Physics B. 34(12). 120502–120502.
2.
Liu, Ke, Feifei Yang, Ke Chen, et al.. (2025). Curcumin mediates oxidative stress to play an anti-fibrotic role, focusing on liver, renal, myocardial and pulmonary fibrosis. Frontiers in Pharmacology. 16. 1636538–1636538.
4.
He, Zhangxu, Ziqiao Yuan, Feifei Yang, et al.. (2024). A comprehensive review on DCN1 protein, inhibitors and their therapeutic applications. International Journal of Biological Macromolecules. 277(Pt 4). 134541–134541. 3 indexed citations
5.
Shan, Peipei, Chao Wang, Kongkai Zhu, et al.. (2024). First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway. Acta Pharmaceutica Sinica B. 14(5). 2177–2193. 10 indexed citations
6.
Zhu, Sujie, Jie Yu, Rui Zhou, et al.. (2024). Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy. Cell Communication and Signaling. 22(1). 361–361. 9 indexed citations
7.
Liu, Shujun, Chenxi Ouyang, Ahmed M. E. Abdalla, et al.. (2024). The long coiled-coil protein NECC2 regulates oxLDL-induced endothelial oxidative damage and exacerbates atherosclerosis development in apolipoprotein E −/− mice. Free Radical Biology and Medicine. 216. 106–117. 4 indexed citations
8.
Campbell, Kim, Katherine Li, Feifei Yang, et al.. (2023). Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab. ImmunoHorizons. 7(4). 273–285. 7 indexed citations
9.
Hu, Xiaohui, et al.. (2023). Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth. Cell Death and Disease. 14(12). 801–801. 15 indexed citations
10.
Pavlidis, Polychronis, Anastasia Tsakmaki, Agatha Treveil, et al.. (2022). Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease. Cell Reports. 40(13). 111439–111439. 22 indexed citations
11.
Shan, Peipei, Feifei Yang, Hongzhao Qi, et al.. (2021). Alteration of MDM2 by the Small Molecule YF438 Exerts Antitumor Effects in Triple-Negative Breast Cancer. Cancer Research. 81(15). 4027–4040. 41 indexed citations
12.
Yang, Feifei, et al.. (2021). The iron chelator deferoxamine decreases myeloma cell survival. Journal of International Medical Research. 49(1). 1220786948–1220786948. 3 indexed citations
13.
Li, Katherine, Colleen Marano, Hongyan Zhang, et al.. (2020). Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis. Gastroenterology. 159(6). 2052–2064. 63 indexed citations
14.
He, Zhangxu, Hui Qiao, Feifei Yang, et al.. (2019). Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent. European Journal of Medicinal Chemistry. 184. 111764–111764. 54 indexed citations
15.
Ye, Mingzhu, Xiaoyu Zhang, Ling Dong, et al.. (2018). A method of elevated temperatures coupled with magnetic stirring to predict real time release from long acting progesterone PLGA microspheres. Asian Journal of Pharmaceutical Sciences. 14(2). 222–232. 13 indexed citations
16.
Yang, Feifei, Miao Tian, Yumei Wang, et al.. (2016). Long Noncoding RNA Highly Upregulated in Liver Cancer Regulates the Tumor Necrosis Factor-α-Induced Apoptosis in Human Vascular Endothelial Cells. DNA and Cell Biology. 35(6). 296–300. 41 indexed citations
17.
Hu, Xiao, Feifei Yang, & Yonghong Liao. (2016). Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery. Current Pharmaceutical Design. 22(17). 2532–2548. 15 indexed citations
18.
Wu, Jing, Feifei Yang, Jingjie Li, et al.. (2014). Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents. European Journal of Medicinal Chemistry. 80. 340–351. 48 indexed citations
19.
Yang, Feifei, et al.. (2012). Preparation andin vitro/in vivoevaluation of a ketoprofen orally disintegrating/sustained release tablet. Drug Development and Industrial Pharmacy. 39(6). 928–934. 12 indexed citations
20.
Friedrichs, William E., et al.. (1995). Expression and Inflammatory Regulation of Haptoglobin Gene in Adipocytes. Biochemical and Biophysical Research Communications. 209(1). 250–256. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026